Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study (2021)
Attributed to:
Interrogating disease clusters, multimorbidity and adverse outcomes in chronic kidney disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 398
Parent Publication: LANCET
Issue: 10296
ISSN: 0140-6736